Home > Journals > Chirurgia > Past Issues > Chirurgia 2021 October;34(5) > Chirurgia 2021 October;34(5):222-6

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

CASE REPORT   

Chirurgia 2021 October;34(5):222-6

DOI: 10.23736/S0394-9508.20.05227-4

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Breast implant-associated anaplastic large cell lymphoma: case report and literature review

Rebecca J. FISHER 1 , Kishan P. PAREKH 1, Rebecca HARSTEN 2, Philip IDAEWOR 1, Abdalla SAAD ABDALLA AL-ZAWI 1, Wayne CHICKEN 1

1 Department of Surgery, Basildon and Thurrock University Hospital, Basildon, UK; 2 Department of Surgery, Royal London Hospital, London, UK



The number of reported cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is increasing along with attention and discussion amongst physicians. After first being described in 1997, the World Health Organization in 2016 classified BIA-ALCL as a mature T cell neoplasm. This increasing acknowledgment and awareness will help in guiding management towards appropriate diagnosis and effective treatment. BIA-ALCL is originally a T-cell lymphoma, where the malignant T-cells have a large pleomorphic and anaplastic morphology. The immuno-histochemistry expresses immuno-reactivity to CD30. It is an anaplastic lymphoma kinase (ALK) surface receptor negative anaplastic large cell lymphoma. We present an additional case of BIA-ALCL, the presentation and management; and provide an overview of the literature related to this condition.


KEY WORDS: Lymphoma, large-cell, anaplastic; T-lymphocytes, cytotoxic; Breast implants

top of page